Xuebiao Yao to Prostatic Neoplasms
This is a "connection" page, showing publications Xuebiao Yao has written about Prostatic Neoplasms.
Connection Strength
0.628
-
Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009 Oct; 104(7):1009-16.
Score: 0.156
-
Dai B, Kong YY, Ye DW, Ma CG, Zhou XY, Yao XD. Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy. Asian J Androl. 2008 Sep; 10(5):701-9.
Score: 0.150
-
Zhou Z, Yue F, Jin L, Liu X, Zhai TS, Zhang JX, Gu WY, Liu SH, Luo M, Peng B, Yao XD, Ye L. Characteristics and risk differences of different tumor size on localized prostate cancer: A retrospective cohort study in the SEER database. Cancer Med. 2021 04; 10(8):2763-2773.
Score: 0.089
-
Zhai TS, Jin L, Hu LT, Kadier A, Zhou Z, Liu X, Liu H, Li S, Lu JY, Yao XD, Ye L. Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy. Urol Oncol. 2020 02; 38(2):37.e1-37.e9.
Score: 0.082
-
Zhou JQ, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Ye DW. [Necessity analysis of bone scan in patients with newly diagnosed prostate cancer]. Zhonghua Yi Xue Za Zhi. 2013 Jan 22; 93(4):248-51.
Score: 0.051
-
Wan FN, Zhu Y, Zhou JQ, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL. [Evaluation of perioperative complications in the elderly with radical prostatectomy]. Zhonghua Wai Ke Za Zhi. 2012 Nov; 50(11):995-8.
Score: 0.050
-
Zhou JQ, Zhu Y, Yao XD, Zhang SL, Dai B, Zhang HL, Ye DW. [The building and validation of a model to predict the bone metastases of patients with newly diagnosed prostate cancer]. Zhonghua Wai Ke Za Zhi. 2012 Nov; 50(11):999-1002.
Score: 0.050